Brain-Abundant Membrane-Attached Signaling Protein 1: A promising Drug Target and Biomarker

Target Name: BASP1

NCBI ID: G10409

BASP1

Brain-Abundant Membrane-Attached Signaling Protein 1: A promising Drug Target and Biomarker

Brain-abundant membrane-attached signaling protein 1 (BASP1) is a protein that plays a crucial role in the development and maintenance of the nervous system. It is expressed in various tissues, including brain, heart, and kidneys, and its function is essential for the survival and proper functioning of these organs. BASP1 has been identified as a potential drug target and biomarker due to its unique expression patterns and its involvement in various signaling pathways.

Expression and Localization

BASP1 is a member of the transmembrane protein family, which means that it spans the cell membrane and is involved in various signaling processes. It is predominantly expressed in the brain, where it is found in various tissues, including neurons, glial cells, and microglia. BASP1 is also expressed in other tissues, including heart and kidneys, but its levels are much lower than in the brain.

BASP1 localizes to the endoplasmic reticulum (ER) and the trans-endosomal system, which transports it to the cell surface for its functions. It is involved in various signaling pathways, including cell adhesion, migration, and survival.

Function and Interaction

BASP1 is involved in several critical signaling pathways that are essential for the development and maintenance of the nervous system. One of the most well-studied functions of BASP1 is its role in cell adhesion. It is a critical protein for the formation of tight junctions, which are essential for the separation of tissues and the formation of organs.

BASP1 is also involved in the regulation of cell migration. It has been shown to promote the migration of neurons and glial cells to the site of injury or disease, which is crucial for the repair and regeneration of the nervous system.

BASP1 plays a vital role in the regulation of cell survival. It has been shown to protect neurons from various forms of stress, including oxidative stress, UV radiation, and temperature changes.

Drug Target and Biomarker

BASP1 is a potential drug target due to its unique expression patterns and its involvement in various signaling pathways. Several studies have shown that inhibiting BASP1 can lead to therapeutic effects in various neurological and cardiovascular diseases.

One of the most promising strategies for targeting BASP1 is the use of small molecules that can inhibit its activity. Several inhibitors have been shown to have therapeutic effects in various models of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Another approach to targeting BASP1 is the use of antibodies that can specifically recognize and block its function. Several antibodies have been shown to have therapeutic effects in various models of neurodegenerative diseases.

Conclusion

BASP1 is a protein that plays a crucial role in the development and maintenance of the nervous system. Its unique expression patterns and its involvement in various signaling pathways make it an attractive drug target and biomarker. Several studies have shown that inhibiting BASP1 or using antibodies to specifically recognize and block its function can lead to therapeutic effects in various neurological and cardiovascular diseases. Further research is needed to fully understand the role of BASP1 in the nervous system and its potential as a drug target and biomarker.

Protein Name: Brain Abundant Membrane Attached Signal Protein 1

The "BASP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BASP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets